Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Mirum Pharmaceuticals, Inc. issued 1,000,000 shares of common stock to entities associated with TCG Crossover Management, LLC for aggregate gross purchase price of approximately $68,480,000.
- Security
- common stock
- Shares
- 1,000,000 shares
- Purchaser
- entities associated with TCG Crossover Management, LLC
- Consideration
- aggregate gross purchase price of approximately $68,480,000
Exact text from the filing
On December 18, 2025, Mirum Pharmaceuticals, Inc. (the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with entities associated with TCG Crossover Management, LLC (“TCGX”), an institutional investor (the “PIPE Investors”), pursuant to which the PIPE Investors have agreed, subject to the terms and conditions of the Subscription Agreement, to purchase immediately following the Closing (as defined below), 1,000,000 shares (the “PIPE Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for an aggregate gross purchase price of approximately $68,480,000 (the “Private Placement”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Mirum Pharmaceuticals, Inc. entered into Subscription Agreement with entities associated with TCG Crossover Management, LLC valued at approximately $68,480,000 (effective 2025-12-18).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- entities associated with TCG Crossover Management, LLC
- Value
- approximately $68,480,000
- Effective
- 2025-12-18
Exact text from the filing
On December 18, 2025, Mirum Pharmaceuticals, Inc. (the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with entities associated with TCG Crossover Management, LLC (“TCGX”), an institutional investor (the “PIPE Investors”), pursuant to which the PIPE Investors have agreed, subject to the terms and conditions of the Subscription Agreement, to purchase immediately following the Closing (as defined below), 1,000,000 shares (the “PIPE Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for an aggregate gross purchase price of approximately $68,480,000 (the “Private Placement”).
View on SEC.gov